EP3749353
NEMOLIZUMAB IN THE TREATMENT OF ATOPIC DERMATITIS WITH MODERATE TO SEVERE EXCORIATION
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
8.2.2019:
30.7.2025:
19710488.8
:
7.2.2039:
7.2.2026
:
NEMOLIZUMAB IN THE TREATMENT OF ATOPIC DERMATITIS WITH MODERATE TO SEVERE EXCORIATION
8.2.2019
30.7.2025
7.2.2026
:
Galderma Holding SA:
Rue d'Entre-deux-Villes, 10, 1814 La Tour-de-Peilz, CH
:
Chugai Seiyaku Kabushiki Kaisha:
5-1, Ukima 5-chome, Kita-ku Tokyo 115-8543, JP
:
KERROUCHE, Nabil:
06650 Le Rouret, FR
:
HIROKAWA, Keiko:
Tokyo, Tokyo 103-8324, JP
:
MIHARA, Ryosuke:
Tokyo, Tokyo 103-8324, JP
:
201862628714 P:
9.2.2018:
US
:
IB2019051051:
8.2.2019
:
A61K 39/00, A61P 17/04, C07K 16/28